Shenzhen, Guangdong, China – November 5, 2026 – Shenzhen Sunsred Technology Co., Ltd., an established manufacturer of medical-grade light therapy equipment, has announced the launch of its new Aura series
Sunsred Will Showcase its Newly Launched AURA Series at the 29th Cosmoprof Asia in Hong Kong in 2026.
The Key Myelodysplastic Syndrome Companies in the market include – Geron, Servier, AbbVie, OrcaBio, Rigel Pharmaceuticals, University Hospital, Grenoble, Kind Pharmaceuticals LLC, Otsuka Beijing Research Institute, Agios Pharmaceuticals, Bristol-Myers Squibb,
(Albany, New York) – November 05, 2026: As per DelveInsight’s assessment, globally, Acute Lymphocytic Leukemia pipeline constitutes 120+ key companies continuously working towards developing 125+ Acute Lymphocytic Leukemia treatment therapies,
The market dynamics for Acid Sphingomyelinase Deficiency (ASMD) are expected to witness steady growth driven by increasing disease awareness, improved genetic testing and diagnosis rates, and the growing demand for
The market dynamics for Antiphospholipid Syndrome (APS) are expected to witness growth driven by the rising prevalence of autoimmune disorders,
The market dynamics for Buerger’s disease are expected to evolve through 2036, driven by the high unmet medical need for
The Pheochromocytoma and Paraganglioma market analysis report delivers important insights into ongoing research on pipeline Pheochromocytoma and Paraganglioma drugs, clinical
The T-Cell Malignancies market analysis report delivers important insights into ongoing research on pipeline T-Cell Malignancies drugs, clinical strategies, upcoming
The Psoriatic Arthritis market analysis report delivers important insights into ongoing research on pipeline Psoriatic Arthritis drugs, clinical strategies, upcoming
The Cancer Pain market analysis report delivers important insights into ongoing research on pipeline Cancer Pain drugs, clinical strategies, upcoming
